# A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection

> **NCT05584683** · PHASE1 · COMPLETED · sponsor: **Kaizen Bioscience Co.** · enrollment: 39 (actual)

## Conditions studied

- Pediatric
- Bacterial Infections

## Interventions

- **DRUG:** Amoxicillin potassium clavulanate
- **DRUG:** Amoxicillin potassium clavulanate (Augmentin ES-600)

## Key facts

- **NCT ID:** NCT05584683
- **Lead sponsor:** Kaizen Bioscience Co.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-09
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-16
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584683, "A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05584683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*